Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia: Evidence From Pharmacogenetics in the Light of Personalized Medicine

NCT02205437 is registered in ClinicalTrials.gov with Fundación Marques de Valdecilla as lead sponsor.

NCT NCT02205437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02205437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Candidate Genes for Treatment Response to Antipsychotics in Schizophrenia: Evidence From Pharmacogenetics in the Light of Personalized Medicine
Lead sponsor
Fundación Marques de Valdecilla
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2015
Completion date
December 31, 2020
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia